BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28598086)

  • 1. [High Mobility Group Chromosomal Protein N2 Inhibit Cervical Cancer Transplanted in Nude Mice].
    Luo B; Zhang QW; Xu Y; Meng J; Wang XL; Li L; He YD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):718-721. PubMed ID: 28598086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effects of high mobility group chromosomal protein N2 on human tongue carcinoma transplanted in nude mice].
    Liu X; Dong X; Zhang Y; Zhang P; Li X; Chen S; Feng Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Feb; 32(1):5-8. PubMed ID: 24665631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high-intensity focused ultrasound in combination with cisplatin using a Xenograft model of cervical cancer.
    Lee YY; Cho YJ; Choi JJ; Choi CH; Kim TJ; Kim BG; Bae DS; Kim YS; Lee JW
    Anticancer Res; 2012 Dec; 32(12):5285-9. PubMed ID: 23225428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGN2 protein inhibits the growth of infected T24 cells in vitro.
    Wei D; Zhang P; Zhou M; Feng Y; Chen Q
    J Cancer Res Ther; 2014; 10(2):299-304. PubMed ID: 25022381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines.
    Liang G; Xu E; Yang C; Zhang C; Sheng X; Zhou X
    Oncol Rep; 2015 Mar; 33(3):1300-6. PubMed ID: 25530340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
    Murakami T; Murata T; Kawaguchi K; Kiyuna T; Igarashi K; Hwang HK; Hiroshima Y; Hozumi C; Komatsu S; Kikuchi T; Lwin TM; Delong JC; Miyake K; Zhang Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):61-65. PubMed ID: 28011474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells.
    Fan B; Shi S; Shen X; Yang X; Liu N; Wu G; Guo X; Huang N
    Oncol Lett; 2019 Jan; 17(1):1160-1166. PubMed ID: 30655878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of emodin on the growth of cervical cancer in tumor-transplanted mice and underlying mechanism].
    Zhang J; Hu Z; Chen Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):350-4. PubMed ID: 25744842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Role of HMGN2 in the Development of Periodontitis Dental Plaque].
    Luo Y; Li Q; Fan YP; Chen J; Zhang P; Feng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):491-494. PubMed ID: 28591948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of IL-24 and cisplatin inhibits cervical cancer growth in a xenograft nude mice model.
    Li L; Wang ZX; Wang ZH
    Asian Pac J Cancer Prev; 2011; 12(12):3293-8. PubMed ID: 22471469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapeutic effect and molecular mechanisms of metformin and cisplatin in human lung cancer xenografts in nude mice.
    Chen YQ; Chen G
    J Cancer Res Ther; 2015; 11(2):324-30. PubMed ID: 26148594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
    Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice].
    Dai M; Luo RC; Zheng DY; Lü CW; Ding XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group protein N2 (HMGN2) inhibited the internalization of Klebsiella pneumoniae into cultured bladder epithelial cells.
    Wu G; Cao Y; Fan B; Zheng F; Gao X; Liu N; Liu X; Huang N
    Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):680-7. PubMed ID: 21778192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
    Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of HMGN2-tag constructs to analysis of HMGN2 distribution in HeLa cells].
    Xiong W; Feng Y; Huang N; Wu Q; Li X; Wang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):1015-9. PubMed ID: 16294743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.